South Dakota Investment Council Amgen Inc Transaction History

South Dakota Investment Council

$5.12 Billion
Q3 2024

A detailed history of South Dakota Investment Council transactions in Amgen Inc stock. As of the latest transaction made, South Dakota Investment Council holds 30,243 shares of AMGN stock, worth $7.97 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

30,243

Previous 37,578 19.52%

Holding current value

$7.97 Million

Previous $11.7 Million 17.0%

% of portfolio

0.19%

Previous 0.24%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$309.38 - $337.38 $2.27 Million - $2.47 Million	-7,335 Reduced 19.52%	30,243 $9.75 Million
Q2 2024 Aug 08, 2024	SELL	$262.75 - $319.31 $240,679 - $292,487	-916 Reduced 2.38%	37,578 $11.7 Million
Q4 2023 Feb 01, 2024	SELL	$255.7 - $288.46 $1.45 Million - $1.63 Million	-5,661 Reduced 12.82%	38,494 $11.1 Million
Q3 2023 Nov 07, 2023	SELL	$218.65 - $271.46 $8.13 Million - $10.1 Million	-37,199 Reduced 45.72%	44,155 $11.9 Million
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $1.03 Million - $1.22 Million	-4,809 Reduced 5.58%	81,354 $18.1 Million
Q4 2022 Feb 07, 2023	SELL	$229.03 - $291.01 $6.49 Million - $8.24 Million	-28,317 Reduced 24.74%	86,163 $22.6 Million
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $211,890 - $238,973	-944 Reduced 0.82%	114,480 $25.8 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $3.35 Million - $3.72 Million	-14,505 Reduced 11.16%	115,424 $28.1 Million
Q1 2022 May 10, 2022	SELL	$219.27 - $242.57 $9.68 Million - $10.7 Million	-44,136 Reduced 25.36%	129,929 $31.4 Million
Q4 2021 Feb 08, 2022	BUY	$198.88 - $227.6 $10.7 Million - $12.3 Million	53,830 Added 44.77%	174,065 $39.2 Million
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $1.9 Million - $2.23 Million	8,970 Added 8.06%	120,235 $25.6 Million
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $4.02 Million - $4.46 Million	-17,220 Reduced 13.4%	111,265 $27.1 Million
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $1.27 Million - $1.48 Million	5,739 Added 4.68%	128,485 $32 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $10.6 Million - $12.6 Million	48,990 Added 66.42%	122,746 $28.2 Million
Q3 2020 Nov 06, 2020	BUY	$234.65 - $260.95 $58,662 - $65,237	250 Added 0.34%	73,756 $18.7 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $231,437 - $284,005	-1,170 Reduced 1.57%	73,506 $17.3 Million
Q1 2020 May 11, 2020	SELL	$182.24 - $241.7 $1.3 Million - $1.72 Million	-7,135 Reduced 8.72%	74,676 $15.1 Million
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $4.92 Million - $6.33 Million	-26,010 Reduced 24.12%	81,811 $19.7 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $367,372 - $440,188	-2,110 Reduced 1.92%	107,821 $20.9 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $8.98 Million - $10.5 Million	53,840 Added 95.99%	109,931 $20.3 Million
Q1 2019 May 03, 2019	SELL	$180.87 - $203.88 $2.5 Million - $2.81 Million	-13,800 Reduced 19.75%	56,091 $10.7 Million
Q4 2018 Feb 06, 2019	SELL	$178.4 - $208.25 $784,960 - $916,300	-4,400 Reduced 5.92%	69,891 $13.6 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $1.06 Million - $1.19 Million	-5,700 Reduced 7.13%	74,291 $15.4 Million
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $489,847 - $550,204	2,950 Added 3.83%	79,991 $14.8 Million
Q1 2018 May 10, 2018	SELL	$169.43 - $198.0 $19.1 Million - $22.3 Million	-112,589 Reduced 59.37%	77,041 $13.1 Million
Q4 2017 Feb 09, 2018	SELL	$168.79 - $188.59 $7.21 Million - $8.05 Million	-42,700 Reduced 18.38%	189,630 $33 Million
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $38.9 Million - $44.4 Million	232,330	232,330 $43.3 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

News

Stay updated on South Dakota Investment Council with notifications on news.

Account

South Dakota Investment Council Amgen Inc Transaction History